EAST LIVERPOOL, Ohio (MyValleyTributes) – Fonda R. Moffett, age 63, of East Liverpool, passed away on Friday, December 12, ...

(9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in gastric cancer evaluating cadonilimab, a first-in-class ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global ...

Wondering if Akeso is still a smart buy after its big run up, or if the best days are already priced in? You are not alone. That is exactly what we are going to unpack. The stock has cooled slightly ...

Akeso, Inc. (9926.HK) (Akeso or the Company) announced the presentation of a Phase II clinical study that included a ...

The “Gifting for Seniors” drive has been a yearly holiday event since 2020, but this is the most presents the program has ...

Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease progression in patients with HER2-positive metastatic breast cancer, ...

Since its launch, Rezdiffra has made steady commercial progress. In the third quarter, Madrigal's single approved product ...

Netcare Akeso’s Crisis Line Manager, Megan Gonsalves, offers expert guidance for navigating the festive season when you’re on ...

Netcare Akeso’s Crisis Line Manager, Megan Gonsalves shares her essential mental health tips for navigating the festive ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that data from the Phase II study (COMPASSION-25) for its first-in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, in combination with ...

Akeso, Inc. (9926.HK) (Akeso or the Company) announced that at the 2025 ESMO Asia Congress, updated results from the pivotal ...